Gloria L. Hwang

Gloria L. Hwang

Auto-generated profile, based on publicly available information

Gloria L. Hwang

Division of Interventional Radiology, Stanford Health Care, Stanford, CA, United States

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
TATroy K. Adebar
Troy K. Adebar
JGJoseph D. Greer
Joseph D. Greer
PLPaul F. Laeseke
Paul F. Laeseke
GHGloria L. Hwang
Gloria L. Hwang
AOAllison M. Okamura
Allison M. Okamura
Objective: Robotic needle steering systems have the potential to improve percutaneous interventions such as radiofrequency ablation of liver tumors, but steering techniques described to date have not achieved sufficiently small radius of curvature in biological tissue to be relevant to this application. In this study, the impact of tip geometry on steerable needle curvature was examined. Methods: Finite-element simulations and experiments with bent-tip needles in ex vivo liver tissue were performed. Motivated by the results of this analysis, a new articulated-tip steerable needle was designed, in which a distal section is actively switched by a robotic system between a straight tip (resulting in a straight path) and a bent tip (resulting in a curved path). Results: Selection of tip length and angle can greatly improve curvature, with radius of curvature below 5 cm in liver tissue possible through judicious selection of these parameters. An articulated-tip mechanism allows the tip length and angle to be increased, while the straight configuration allows the needle tip to still pass through an introducer sheath and rotate inside the body. Conclusion: Validation testing in liver tissue shows that the new articulated-tip steerable needle achieves smaller radius of curvature compared to bent-tip needles described in previous work. Significance: Steerable needles with optimized tip parameters, which can generate tight curves in liver tissue, increase the clinical relevance of needle steering to percutaneous interventions.

1 February 2016 in Radiology
Verified
Journal Article
Closed access
FDFeng Duan
Feng Duan
EWEllen Q. Wang
Ellen Q. Wang
Floris H.P. Van VeldenFloris H.P. Van Velden
Floris H.P. Van Velden
MAMohamed H. K. Abdelmaksoud
Mohamed H. K. Abdelmaksoud
JLJohn Louie
John Louie
DSDaniel Y. Sze
Daniel Y. Sze
Purpose To study the comparative short-term safety and efficacy of transcatheter arterial chemoembolization (TACE) with drug-eluting LC Beads loaded with doxorubicin (DEBDOX), doxorubicin-eluting QuadraSpheres (hqTACE), and conventional TACE using ethiodized oil for superselective C-arm computed tomography (CT)-guided treatment of hepatocellular carcinoma (HCC) after the onset of drug shortages. Materials and Methods From March 2010 to March 2011, 166 patients with HCC were treated with 232 superselective TACE procedures using C-arm cone-beam CT at one institution. Patients underwent treatment depending on the availability of materials after the onset of drug shortages. Conventional TACE with doxorubicin, cisplatin, and Ethiodol was performed for 159 procedures, DEBDOX TACE was performed for 47, and hqTACE was performed for 26. Toxicity and objective response were compared at 3 months after treatment. Data were stratified for the high-risk population (Child-Pugh class B, performance status 1, bilobar disease, and/or post-resection recurrence) and initial versus repeat treatment. Kruskal-Wallis H test, Mann-Whitney U test, and Fisher exact test were used to compare the groups, with Bonferroni correction where needed. Results Whole liver response rates trended higher for conventional TACE (conventional TACE, 65.4%; DEBDOX, 63.8%; hqTACE, 53.8%) (P = .085). Only minor trends for differences in toxicity were observed between the three groups. Low-risk patients had higher whole liver (P = .001) and treated lesion (P = .007) response rates when treated with conventional TACE, but no significant differences were seen for DEBDOX and hqTACE. Treatment-naive patients also had higher whole liver (P = .012) and treated lesion (P = .056) response rates. No advantages for drug-eluting microspheres were found. Conclusion Within statistical power limitations, overall toxicity and efficacy were equivalent in patients treated with LC Beads, QuadraSpheres, or ethiodized oil emulsions, including in high-risk patients, when performed superselectively with cone-beam C-arm CT guidance. © RSNA, 2015

14 February 2017 in IEEE Robotics and Automation Letters
Verified
Journal Article
Closed access
GGGiada Gerboni
Giada Gerboni
JGJoseph D. Greer
Joseph D. Greer
PLPaul F. Laeseke
Paul F. Laeseke
GHGloria L. Hwang
Gloria L. Hwang
AOAllison M. Okamura
Allison M. Okamura
Robotic needle steering will improve percutaneous radio-frequency ablation (RFA) in the liver by performing distributed ablations without requiring multiple punctures of the liver capsule, thus enabling the treatment of large or multifocal tumors. However, state-of-the-art asymmetric-tip robotic needle steering systems do not yet achieve clinically relevant curvature. This work presents the design and development of a highly articulated needle that enables distributed RFA in liver tissue under ultrasound (US) image guidance. Our new needle design attains the target curvature required for liver procedures while meeting important clinical requirements, such as the use of fixed diameter needle introducers, presence of a free needle working channel, robustness for repeated insertions, and conductivity for the delivery of RF current for tissue ablation. The new needle tip includes two important design features: A tendon-actuated Nitinol asymmetric flexure joint, which allows for an active amplification of the needle steering force, and a steel back-bevel tip profile, which decreases the risk of needle jamming. The needle's resulting curvature was evaluated in both phantom and ex vivo liver tissues using segmented US images. The average radius of minimum curvature in ex vivo liver tissue was found to be 33.6 mm, the smallest reported to date. Furthermore, RFA in ex vivo porcine liver tissue tests were performed to demonstrate that distributed ablation with a single puncture of the liver capsule is possible via robotic needle steering.

1 September 2016 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
MSMichael B. Sano
Michael B. Sano
RFRichard E. Fan
Richard E. Fan
GHGloria L. Hwang
Gloria L. Hwang
GSGeoffrey Alexander Sonn
Geoffrey Alexander Sonn
Lei XingLei Xing
Lei Xing

2 May 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
NBNam Quoc Bui
Nam Quoc Bui
NNNeda Nemat-Gorgani
Neda Nemat-Gorgani
ASAjay Subramanian
Ajay Subramanian
ITIleana A. Torres
Ileana A. Torres
MLMarta Lohman
Marta Lohman
EMEverett J. Moding
Everett J. Moding
Purpose: Immune checkpoint inhibition has led to promising responses in soft tissue sarcomas (STS), but the majority of patients do not respond and biomarkers of response will be crucial. Local ablative therapies may augment systemic responses to immunotherapy. We evaluated circulating tumor DNA (ctDNA) as a biomarker of response in patients treated on a trial combining immunotherapy with local cryotherapy for advanced STS. Patients and Methods: We enrolled 30 patients with unresectable or metastatic STS to a phase II clinical trial. Patients received ipilimumab and nivolumab for four doses followed by nivolumab alone with cryoablation performed between cycles 1 and 2. The primary endpoint was objective response rate (ORR) by 14 weeks. Personalized ctDNA analysis using bespoke panels was performed on blood samples collected prior to each immunotherapy cycle. Results: ctDNA was detected in at least one sample for 96% of patients. Pretreatment ctDNA allele fraction was negatively associated with treatment response, progression-free survival (PFS), and overall survival (OS). ctDNA increased in 90% of patients from pretreatment to postcryotherapy, and patients with a subsequent decrease in ctDNA or undetectable ctDNA after cryotherapy had significantly better PFS. Of the 27 evaluable patients, the ORR was 4% by RECIST and 11% by irRECIST. Median PFS and OS were 2.7 and 12.0 months, respectively. No new safety signals were observed. Conclusions: ctDNA represents a promising biomarker for monitoring response to treatment in patients with advanced STS, warranting future prospective studies. Combining cryotherapy and immune checkpoint inhibitors did not increase the response rate of STS to immunotherapy.

1 December 2021 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ADAnkur Doshi
Ankur Doshi
MZMaggie Yuxi Zhou
Maggie Yuxi Zhou
NBNam Quoc Bui
Nam Quoc Bui
DWDavid S. Wang
David S. Wang
KGKristen N. Ganjoo
Kristen N. Ganjoo
GHGloria L. Hwang
Gloria L. Hwang